[140] 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 
| PRODUCT NAME | CAS Registry Number | ||||||||
| BCL-2 BINDING PEPTIDE, CELL PERMEABLE (0 suppliers) | |||||||||
Bcl-2 Inhibitor (5 suppliers)
IUPAC Name: 4-methoxy-2-[2-(5-methoxy-2-nitrosophenyl)ethyl]-1-nitrosobenzene | CAS Registry Number: 383860-03-5Synonyms: 2,9-Dimethoxy-11,12-dihydrodibenzo[c,g][1,2]-diazocine 5,6-dioxide (A) and 5,5′-Dimethoxy-2,2′-dinitrosobenzyl (B), AGN-PC-00GVQI, CTK8E8848, HSCI1_000193, IN1522, Benzene, 1,1'-(1,2-ethanediyl)bis[5-methoxy-2-nitroso-
InChIKey: YPSXFMHXRZAGTG-UHFFFAOYSA-N | 383860-03-5 | ||||||||
| Bcl-2 Inhibitor II, YC137 (0 suppliers) | |||||||||
Bcl-2 Inhibitor III, EM20-25 (3 suppliers)
IUPAC Name: 5-(7-chloro-2,4-dioxo-1,5-dihydrochromeno[2,3-d]pyrimidin-5-yl)-1,3-diazinane-2,4,6-trione | CAS Registry Number: 141266-44-6Synonyms: ST50989532, 5-(6-Chloro-2,4-dioxo-1,3,4,10-tetrahydro-2H-9-oxa-1,3-diaza-anthracen-10-yl)-pyrimidine-2,4,6-trione, AC1NDYEK, EM20-25, 5-(7-chloro-2,4-dioxo-1,3-dihydro-5H-chromeno[2,3-d]pyrimidin-5-yl)-1,3,5-trih ydropyrimidine-2,4,6-trione, 5-(7-chloro-2,4-dioxo-1,5-dihydrochromeno[2,3-d]pyrimidin-5-yl)-1,3-diazinane-2,4,6-trione
InChIKey: GGEVZGGAQHNWQN-UHFFFAOYSA-N | 141266-44-6 | ||||||||
| BCL-2, CERTIFIED REFERENCE MATERIAL (0 suppliers) | |||||||||
| Bcl-2-IN-10 (0 suppliers) | 2773354-28-0 | ||||||||
| Bcl-2-IN-11 (1 supplier) | 2760536-88-5 | ||||||||
| Bcl-2-IN-12 (1 supplier) | 1383737-59-4 | ||||||||
| Bcl-2-IN-13 (1 supplier) | 1421687-31-1 | ||||||||
| Bcl-2-IN-16 (1 supplier) | 2858632-01-4 | ||||||||
| Bcl-2-IN-17 (1 supplier) | 1321801-22-2 | ||||||||
Bcl-2-IN-2 (2 suppliers)
IUPAC Name: 4-[2-[(2S)-2-(2-ethylphenyl)pyrrolidin-1-yl]-7-azaspiro[3.5]nonan-7-yl]-N-[4-[(4-hydroxy-4-methylcyclohexyl)methylamino]-3-nitrophenyl]sulfonyl-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide | CAS Registry Number: 2383085-86-5Synonyms: EX-A4637, HY-131247, CS-0131749
InChIKey: DTVOZSGYTQLYFR-WBEVPWTISA-N | 2383085-86-5 | ||||||||
| Bcl-2-IN-4 (1 supplier) | 2703134-40-9 | ||||||||
| Bcl-2-IN-5 (1 supplier) | 2728752-20-1 | ||||||||
| BCL-2-IN-6 (1 supplier) | |||||||||
| BCL-2-IN-7 (1 supplier) | |||||||||
| BCL-2-IN-8 (1 supplier) | |||||||||
| Bcl-2-IN-9 (1 supplier) | 2490542-33-9 | ||||||||
| Bcl-2/Mcl-1-IN-1 (1 supplier) | 2673361-08-3 | ||||||||
| Bcl-2/Mcl-1-IN-2 (1 supplier) | 2673361-07-2 | ||||||||
| Bcl-2/Mcl-1-IN-3 (1 supplier) | 2088981-53-5 | ||||||||
| BCL-2_ANTIBODY (0 suppliers) | |||||||||
| BCL-W Protein, Human, Recombinant (His) (1 supplier) | |||||||||
| BCL-X_ANTIBODY (0 suppliers) | |||||||||
Bcl-xL antagonist 2 (5 suppliers)
IUPAC Name: 2-[8-(1,3-benzothiazol-2-ylcarbamoyl)-3,4-dihydro-1H-isoquinolin-2-yl]-1,3-thiazole-4-carboxylic acid | CAS Registry Number: 1235032-75-3Synonyms: CHEMBL3287293, 4-Thiazolecarboxylic acid, 2-[8-[(2-benzothiazolylamino)carbonyl]-3,4-dihydro-2(1H)-isoquinolinyl]-, SCHEMBL3361340, BDBM50020930, HY-12908, CS-0012771, 2-(8-(Benzo[d]thiazol-2-ylcarbamoyl)-3,4-dihydroisoquinolin-2(1H)-yl)thiazole-4-carboxylic acid
InChIKey: PHCCZZHEZZPUGG-UHFFFAOYSA-N | 1235032-75-3 | ||||||||
| BCL-XL BH3 (85-98) (0 suppliers) | |||||||||
| BCL-XL BH3 (85-98)  (0 suppliers) | |||||||||
| BCL-XL Protein, Human, Recombinant (His) (1 supplier) | |||||||||
| BCL-XL Protein, Mouse, Recombinant (aa 1-212, His) (1 supplier) | |||||||||
| BCL-XL(HUMAN, MO, RAT, BOVINE, DOG, PIG, SHEEP, HORSE), CERTIFIED REFERENCE MATERIAL (0 suppliers) | |||||||||
| BCL-XL, HUMAN, RECOMBINANT, FULL LENGTH (0 suppliers) | |||||||||
| BCL-XL-IN-3 (1 supplier) | 1949840-87-2 | ||||||||
| BCL-XL-PHOSPHO-SER62_ANTIBODY (0 suppliers) | |||||||||
| BCL-xL/BCL-2 ligand 1 (1 supplier) | 2941091-91-2 | ||||||||
| BCL10 ANTIBODY (4F8) (0 suppliers) | |||||||||
| BCL10 Protein, Human, Recombinant (His & SUMO) (1 supplier) | |||||||||
| BCL2 ANTAGONIST/KILLER 1 ELISA KIT (BAK1) (0 suppliers) | |||||||||
| BCL2 ANTIBODY (0 suppliers) | |||||||||
| BCL2 ASSACCIATED X PROTEIN ELISA KIT25NG/ML (0 suppliers) | |||||||||
| BCL2 ASSOCIATED DEATH PROMOTER ELISA KIT (BAD) (0 suppliers) | |||||||||
| BCL2 MODIFYING FACTOR ELISA KIT (BMF) (0 suppliers) | |||||||||
| BCL2 Protein, Human, Recombinant (His) (1 supplier) | |||||||||
| BCL2 Protein, Mouse, Recombinant (His) (1 supplier) | |||||||||
| BCL2 Protein, Rat, Recombinant (His) (1 supplier) | |||||||||
| BCL2 SIRNA KIT (0 suppliers) | |||||||||
BCL2-IN-1 (2 suppliers)
IUPAC Name: 4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-N-[4-[(4-methoxycyclohexyl)methylamino]-3-nitrophenyl]sulfonyl-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide | CAS Registry Number: 1257044-75-9Synonyms: Bcl2-IN-1, SCHEMBL523882, SCHEMBL523883, SCHEMBL1699818, CHEMBL3985475, CHEMBL4228713, BDBM189477, BDBM356647, BDBM356652, US10213433, Compound 29, US10213433, Compound 34, HY-135273, CS-0110524, US9174982, 29, US9174982, 34, A-1211212, cis-4-(4-{[2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-en-1-yl]methyl}piperazin-1-yl)-n-[(4-{[(4-methoxycyclohexyl)methyl]amino}-3-nitrophenyl)sulfonyl]-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide, trans-4-(4-{[2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-en-1-yl]methyl}piperazin-1-yl)-n-[(4-{[(4-methoxycyclohexyl)methyl]amino}-3-nitrophenyl)sulfonyl]-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide
InChIKey: CSBKUBOVPUXFLO-UHFFFAOYSA-N | 1257044-75-9 | ||||||||
| BCL2A1 Protein, Human, Recombinant (His) (1 supplier) | |||||||||
| BCL2A1 SIRNA KIT (0 suppliers) | |||||||||
| BCL2L1 ANTIBODY (0 suppliers) | |||||||||
| BCL2L1 SIRNA KIT (0 suppliers) |